1. United States Pharmacopeia and National Formulary USP 41- NF 36. The United States Pharmacopeial Convention, Rockville. 2018.
2. Nelson E. Solution rate of theophylline salts and effects from oral administration. J Am Pharm Assoc. 1957;46(10):607–14. https://doi.org/10.1002/jps.3030461012.
3. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Office of Generic Drugs/Office of Generic Drugs Policy. Approved Drug Products With Therapeutic Equivalence Evaluations. https://www.fda.gov/media/71474/download?attachment. 2024. Accessed 24 Mar 2024.
4. Grady H, Elder D, Webster GK, Mao Y, Lin Y, Flanagan T, et al. Industry’s view on using quality control, biorelevant, and clinically relevant dissolution tests for pharmaceutical development, registration, and commercialization. J Pharm Sci. 2018;107(1):34–41. https://doi.org/10.1016/j.xphs.2017.10.019.
5. Uddin R, Saffoon N, Sutradhar KB. Dissolution and dissolution apparatus: a review. Int J Cur Biomed Phar Res. 2011;1(4):201–7.